Long-Term Results of Patients' Self-Management of Oral Anticoagulation

Journal of Clinical and Basic Cardiology

Volumn 6, Issue 1-4, 2003, Pages 59-62

  Sawicki, P T ^a   Glaser B ^a   Kleespies, C ^a   Stubbe, J ^a   Schmitz, N ^b   Kaiser, T ^a   Didjurgeit, U ^a  

^a St Franziskus Hospital Koln   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Bleeding; Oral anticoagulation; Quality of life; Self management; Teaching and treatment programme; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN ANTICOAGULANT;

ACCURACY; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SELF MEDICATION; SELF MONITORING; THROMBOEMBOLISM;

EID: 0347384164     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine optimal intensity of oral anticoagulation therapy. Thromb Haemost 1993; 69: 236-9.
2. Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thromboembolic and hemorrhagic complications in patients with mechanic heart valves attending an anticoagulation clinic. Thromb Haemost 1993; 4: 316-20.
3. Ansell JE. Anticoagulation management as risk factor for adverse events: grounds for improvement. J Thromb Thrombolys 1998; 5: 13-8.
4. Ansell JE. Empowering patients to monitor and manage oral anticoagulation therapy. JAMA 1999; 281: 182-3.
5. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation. JAMA 1999; 281: 145-50.
6. Cromheecke ME, Levi M, Colly LP, de Mol BJM, Prins MH, Hutten BA, Mak R, Keyzers KC, Büller HR. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 2000; 356: 97-102.
7. Watzke HH, Forberg E, Svolba G, Jemenez-Boj E, Krinnger B. A prospective controlled trial comparing weekly self-testing and self-dosing with standard management of patients on stable oral anticoagulation. Thromb Haemost 2000; 83: 661-5.
8. Kullina W, Ney D, Wenzel T, Heene DL, Harenberg J. The effect of self monitoring of INR on the quality of anticoagulation and the quality of life. Semin Thromb Hemost 1999; 25: 123-6.
9. Fitzmaurice DA, Machin SJ, on behalf of the British Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self management of oral anticoagulation. BMJ 2001; 323: 985-9.
10. van den Besselaar AMHP, Breddin K, Parker-Williams J, Taborski U, Vogel G, Trischler W, Zerback R, Leinberger R. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagulation Fibrinolysis 1995; 6: 726-32.
11. Todd C, Bradley C. Evaluating the design and development of psychological scales. In: Bradley C (ed). Handbook of psychology and diabetes: A guide to psychological measurement in diabetes research and practice. Harwood Academic Publ., Chur, Switzerland, 1994; 15-42.
12. Landefeld CS, Anderson PA, Goodnough LT, Moir TW, Hom DL, Rosenblatt MW, Goldman L. The bleeding severity index: Validation and comparison to other methods for classifying bleeding complications of medical therapy. J Clin Epidemiol 1989; 42: 711-8.
13. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Lawrence Earlbaum Associates, Hillsdale, NJ, 1988.
14. SAS: SAS/STAT Guide for Personal Computers, Version 8 Edition. SAS Institute Inc., Cary, NC, 1997.
15. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995; 155: 2185-9.
16. Hasenkam JM, Kimose HH, Knudsen L, Grønnesby H, Halborg J, Christensen TD, Attermann J, Pilegaard HK. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardio-Thorac Surg 1997; 11: 935-42.
17. Bernardo A. Experience with patients self-management of oral anticoagulation. J Thromb Thrombolys 1996; 2: 321-5.
18. Horstkotte D, Piper C, Wiemer M, Schulte HD, Schultheiss HP. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulation therapy. Eur Heart J 1996; 17 (Suppl): 230.
19. White RH, McCurdy SA, von Marsendorff H, Woodruff DEJ, Leftgroff L. Home prothrombin time monitoring after the initiation of warfarin therapy: a randomised, prospective study. Ann Intern Med 1989; 111: 730-7.
20. Hambidge D. Selfmanagement is the future. BMJ 2002; 324: 486.
21. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M. Musolesi S. Bleeding complications of oral anticoagulant treatment: an interception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-8.
22. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119 (Suppl I): 8S-21S.
23. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulation therapy in patients with non-rheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 332: 1710-1.
24. Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JE, Sørensen HAT. Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort. J Intern Med 1997; 242: 497-503.